BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Harvard Business School
Express Scripts

Generated: December 17, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 040411

« Back to Dashboard

NDA 040411 describes METHIMAZOLE, which is a drug marketed by Eci Pharms Llc, Heritage Pharma, Mylan, Rising Pharms Inc, Sandoz, and Sun Pharm Inds Inc, and is included in seven NDAs. It is available from eighteen suppliers. Additional details are available on the METHIMAZOLE profile page.

The generic ingredient in METHIMAZOLE is methimazole. There are three drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the methimazole profile page.

Summary for 040411

Therapeutic Class:Hormonal Agents, Suppressant (Thyroid)
Formulation / Manufacturing:see details

Pharmacology for NDA: 040411

Medical Subject Heading (MeSH) Categories for 040411

Suppliers and Packaging for NDA: 040411

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
METHIMAZOLE methimazole TABLET;ORAL 040411 ANDA Eon Labs, Inc. 0185-0205 0185-0205-01 100 TABLET in 1 BOTTLE (0185-0205-01)
METHIMAZOLE methimazole TABLET;ORAL 040411 ANDA Eon Labs, Inc. 0185-0205 0185-0205-10 1000 TABLET in 1 BOTTLE (0185-0205-10)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength5MG
Approval Date:Mar 27, 2001TE:ABRLD:No

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength10MG
Approval Date:Mar 27, 2001TE:ABRLD:No

Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Express Scripts
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch: